Jodie E. Giles

506 total citations
11 papers, 329 citations indexed

About

Jodie E. Giles is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jodie E. Giles has authored 11 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 5 papers in Hematology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jodie E. Giles's work include Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Jodie E. Giles is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Jodie E. Giles collaborates with scholars based in Australia, United States and Czechia. Jodie E. Giles's co-authors include Rosemary Sutton, Nicola C. Venn, Glenn M. Marshall, Michelle Haber, Murray D. Norris, Anita Y. Bahar, Luciano Dalla Pozza, Julie N. Hook, Stephen S. Gebarski and D.E. Schteingart and has published in prestigious journals such as Blood, PLoS ONE and Clinical Chemistry.

In The Last Decade

Jodie E. Giles

10 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jodie E. Giles Australia	8	228	168	95	51	49	11	329
Anna Evans United Kingdom	7	157 0.7×	310 1.8×	61 0.6×	7 0.1×	58 1.2×	10	470
Helena Mörse Sweden	10	169 0.7×	76 0.5×	61 0.6×	10 0.2×	24 0.5×	19	312
Per Frisk Sweden	9	57 0.3×	44 0.3×	77 0.8×	9 0.2×	47 1.0×	27	221
John Shelso United States	9	106 0.5×	13 0.1×	179 1.9×	93 1.8×	39 0.8×	10	350
Fleur Vansenne Netherlands	9	34 0.1×	66 0.4×	93 1.0×	15 0.3×	11 0.2×	21	340
Katherine Josephs United Kingdom	8	52 0.2×	25 0.1×	24 0.3×	23 0.5×	38 0.8×	16	243
Elena Magro Spain	8	19 0.1×	156 0.9×	16 0.2×	38 0.7×	36 0.7×	10	277
Tomizo Nishiguchi Japan	8	17 0.1×	67 0.4×	36 0.4×	11 0.2×	33 0.7×	17	230
Robert Wapenaar Netherlands	8	12 0.1×	117 0.7×	37 0.4×	10 0.2×	33 0.7×	25	289

Countries citing papers authored by Jodie E. Giles

Since Specialization

Citations

This map shows the geographic impact of Jodie E. Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodie E. Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodie E. Giles more than expected).

Fields of papers citing papers by Jodie E. Giles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodie E. Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodie E. Giles. The network helps show where Jodie E. Giles may publish in the future.

Co-authorship network of co-authors of Jodie E. Giles

This figure shows the co-authorship network connecting the top 25 collaborators of Jodie E. Giles. A scholar is included among the top collaborators of Jodie E. Giles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodie E. Giles. Jodie E. Giles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Mateos, Marion K., Glenn M. Marshall, Pasquale Barbaro, et al.. (2021). Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia. Haematologica. 107(3). 635–643. 29 indexed citations

Chen, Dan, Rosemary Sutton, Jodie E. Giles, et al.. (2021). Analytical Quality Controls for ddPCR Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia. Clinical Chemistry. 67(10). 1373–1383.

Žaliová, Markéta, Nicola C. Venn, Kirsten Bleckmann, et al.. (2017). Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology. Blood. 129(20). 2771–2781. 73 indexed citations

Sutton, Rosemary, Nicola C. Venn, Tamara Law, et al.. (2017). A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children. British Journal of Haematology. 180(4). 550–562. 27 indexed citations

Mateos, Marion K., Toby N. Trahair, Chelsea Mayoh, et al.. (2016). Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia. Blood. 128(22). 1182–1182. 2 indexed citations

Barbaro, Pasquale, Marion K. Mateos, Luciano Dalla‐Pozza, et al.. (2015). Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity. Blood. 126(23). 4984–4984. 1 indexed citations

Pozza, Luciano Dalla, Nicola C. Venn, Tamara Law, et al.. (2013). Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease. PLoS ONE. 8(10). e76455–e76455. 13 indexed citations

Sutton, Rosemary, Elizabeth Hughes, Anita Y. Bahar, et al.. (2009). Determining the Repertoire of IGH Gene Rearrangements to Develop Molecular Markers for Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia. Journal of Molecular Diagnostics. 11(3). 194–200. 10 indexed citations

Sutton, Rosemary, Nicola C. Venn, Anita Y. Bahar, et al.. (2009). Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia. British Journal of Haematology. 146(3). 292–299. 45 indexed citations

10.

Henderson, Michelle J., Edward Kwan, Alex H. Beesley, et al.. (2007). Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood. 110(2). 632–639. 72 indexed citations

11.

Hook, Julie N., Bruno Giordani, D.E. Schteingart, et al.. (2006). Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease. Journal of the International Neuropsychological Society. 13(1). 21–29. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact